Quantum量子訊息有限公司
← 最新全球產業報告

Automated Antimicrobial Susceptibility Testing Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-01-29 · 152 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 14.87 Bn
2033 年預估規模
USD 41.76 Bn
年複合成長率 CAGR
9.8%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-01-29頁數 152報告編號 CMI2622

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Automated Antimicrobial Susceptibility Testing Market, By Product Type (Consumables and Instruments), By Detection Method (Turbidimetric and Colorimetric), By Application (Antibacterial (Tuberculosis and Sepsis), Antifungal, Anti-parasitic, and Anti-viral), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals, and Pathology/Diagnostic Laboratories), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Automated antimicrobial susceptibility testing products are of two types, consumables and instruments. Consumables used in automated antimicrobial susceptibility testing includes culture & growth media, ready-to-use reagents, complete reagent kits, susceptibility disks, susceptibility plates, and susceptibility cards, among others. Key players offer reagent kits and disposables, which are designed for use with their automated AST instruments, which optimizes workflow and overall laboratory efficiency. Automated microbial identification and antimicrobial susceptibility testing (AST) instruments offer rapid, accurate, and efficient susceptibility testing, thereby enhancing workflow, reducing hands-on time, and enabling rapid reporting. Automated laboratory AST instruments are equipped with Laboratory Information System (LIS) compatible software to enable better compatibility. Market Dynamics Increasing prevalence of antibiotic resistance worldwide is expected to boost the automated antimicrobial susceptibility testing market growth. According to the World Health Organization’s Global Antimicrobial Surveillance System (GLASS) report of January 2018, antibiotic resistance is found among 500,000 people with suspected bacterial infections across 22 countries. The most commonly reported resistant bacteria were Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pneumoniae, followed by Salmonella sp. However, the major restraining factor affecting growth of the automated antimicrobial susceptibility testing market is the product recalls of instruments for failures or for various other reasons. For instance, in 2016, bioMérieux S.A.’s VITEK 2 Gram Positive Susceptibility Test Cards were recalled by the Food and Drug Administration (FDA), as the product could lead to false susceptible results of Staphylococcus spp., Enterococcus spp., and S. agalactiae. This product was terminated in May 2017. Key features of the study • This report provides in-depth analysis of the automated antimicrobial susceptibility testing market, market size (USD Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026 – 2033, considering 2025 as the base year • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players • It profiles key players in the global automated antimicrobial susceptibility testing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies • Key players covered as a part of this study include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc. • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics • The global automated antimicrobial susceptibility testing market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts Market Segmentation • By Product Type o Consumables o Instruments • By Detection Method o Turbidimetric o Colorimetric • By Application o Antibacterial o Tuberculosis o Sepsis o Antifungal o Anti-parasitic o Anti-viral • By End User o Pharmaceutical and Biotechnology Companies o Contract Research Organizations o Hospitals o Pathology/Diagnostic Laboratories • By Regional Insights o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o bioMérieux S.A. o HiMedia Laboratories o Alifax Holding S.p.A. o Creative Diagnostics o Resistell AG o Danaher Corporation o Becton o Dickinson and Company o Thermo Fisher Scientific Inc. o Merck KGaA o Bio-Rad Laboratories, Inc.
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Product Type  Market Snippet, By Detection Method  Market Snippet, By Application  Market Snippet, By End User  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  PEST Analysis  PORTER’s Five Forces Analysis  Market Opportunities  Regulatory Scenario  Key Developments  Industry Trend 4. Global Automated Antimicrobial Susceptibility Testing Market, By Product Type, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Consumables  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Instruments  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 5. Global Automated Antimicrobial Susceptibility Testing Market, By Detection Method, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Turbidimetric  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Colorimetric  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 6. Global Automated Antimicrobial Susceptibility Testing Market, By Application, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Antibacterial  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Tuberculosis  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Sepsis  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Antifungal  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Anti-parasitic  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Anti-viral  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 7. Global Automated Antimicrobial Susceptibility Testing Market, By End User, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Pharmaceutical and Biotechnology Companies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Contract Research Organization  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Hospitals  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Pathology/Diagnostic Laboratories  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 8. Global Automated Antimicrobial Susceptibility Testing Market, By Region, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Region, 2021 - 2033 o North America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Detection Method, 2026- 2033, (USD Bn)  Market Size and Forecast, By Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o U.S. o Canada o Latin America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Detection Method, 2026- 2033, (USD Bn)  Market Size and Forecast, By Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Detection Method, 2026- 2033, (USD Bn)  Market Size and Forecast, By Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Detection Method, 2026- 2033, (USD Bn)  Market Size and Forecast, By Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Detection Method, 2026- 2033, (USD Bn)  Market Size and Forecast, By Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033  Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Detection Method, 2026- 2033, (USD Bn)  Market Size and Forecast, By Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o South Africa o North Africa o Central Africa 9. Competitive Landscape o Heat Map Analysis o Market Share Analysis (3x3 Matrix) o Company Profiles  bioMérieux S.A. o Company Overview o Product Type Portfolio o Recent Developments/Updates  HiMedia Laboratories o Company Overview o Product Type Portfolio o Recent Developments/Updates  Alifax Holding S.p.A. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Creative Diagnostics o Company Overview o Product Type Portfolio o Recent Developments/Updates  Resistell AG o Company Overview o Product Type Portfolio o Recent Developments/Updates  Danaher Corporation o Company Overview o Product Type Portfolio o Recent Developments/Updates  Becton o Company Overview o Product Type Portfolio o Recent Developments/Updates  Dickinson and Company o Company Overview o Product Type Portfolio o Recent Developments/Updates  Thermo Fisher Scientific Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Merck KGaA o Company Overview o Product Type Portfolio o Recent Developments/Updates  Bio-Rad Laboratories, Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates 10. Analyst Recommendation o Wheel of Fortune o Analyst View o Coherent Opportunity Map 11. Section o References o Research Methodology o About Us and Sales Contact

提及公司

bioMérieux S.A.HiMedia LaboratoriesAlifax Holding S.p.A.Creative DiagnosticsResistell AGDanaher CorporationBectonDickinson and CompanyThermo Fisher Scientific Inc.Merck KGaABio-Rad Laboratories, Inc.

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們